cultur
serotyp
human
enterovirus
fluoresc
microscopi
timeconsum
laborintens
flow
cytometri
potenti
rapid
sensit
object
use
purpos
clinic
laboratori
primari
rhesu
monkey
kidney
pmk
cell
inocul
sever
enteroviru
serotyp
stain
enterovirusspecif
antibodi
flow
cytometri
indirect
fluoresc
antibodi
test
ifa
kinet
studi
coxsackieviru
echoviru
infect
pmk
cell
perform
day
inocul
flow
cytometri
result
echoviru
coxsackieviru
correl
ifa
case
coxsackieviru
echoviru
infect
detect
day
earlier
flow
cytometri
ifa
flow
cytometri
effect
use
detect
enterovirusinfect
cell
clinic
laboratori
advantag
better
quantit
low
level
infect
earlier
detect
viral
infect
cell
cultur
system
human
enterovirus
member
picornavirida
famili
among
common
human
pathogen
caus
broad
spectrum
human
diseas
includ
myocard
handfootandmouth
diseas
meningoenceph
paralyt
myeliti
romero
least
serotyp
defin
period
enteroviru
outbreak
occur
major
public
health
concern
khetsuriani
et
al
enterovir
infect
lifethreaten
certain
serotyp
eg
poliovirus
enteroviru
caus
devast
neurolog
damag
death
polioviru
outbreak
still
occur
develop
nation
despit
erad
effort
oral
polioviru
vaccinederiv
strain
increas
caus
viral
paralyt
syndrom
must
differenti
wildtyp
polioviru
caus
paralyt
myeliti
west
nile
viru
coxsackieviru
enteroviru
muir
et
al
henc
capac
classifi
human
enterovirus
clinic
specimen
imper
diseas
prevent
treatment
prognosi
histor
serotyp
enterovirus
accomplish
combin
indirect
fluoresc
antibodi
test
ifa
viral
neutral
assay
use
antisera
pool
provid
world
health
organ
techniqu
timeconsum
laborintens
technic
demand
longer
produc
antisera
viral
neutral
studi
must
obtain
remain
sourc
nation
institut
public
health
environ
rivm
netherland
flow
cytometri
potenti
altern
ifa
serotyp
clinic
isol
provid
quantit
inform
less
interobserv
variabl
flow
cytometri
hundr
cell
analyz
short
period
time
second
increas
sensit
detect
fluoresc
signal
due
use
laser
photomultipli
tube
abil
autom
despit
advantag
ifa
studi
focus
use
flow
cytometri
serotyp
enteroviru
prior
studi
isol
obtain
frozen
repositori
previous
cultur
serotyp
use
serum
neutral
studi
clinic
virolog
laboratori
associ
region
univers
pathologist
arup
laboratori
previous
describ
et
al
enterovir
isol
store
c
prior
use
studi
serotyp
shell
vial
contain
confluent
layer
primari
rhesu
monkey
kidney
pmk
virom
laboratori
minnetonka
mn
inocul
l
echoviru
echoviru
echoviru
echoviru
coxsackieviru
rhinoviru
ml
minimum
essenti
medium
mem
fetal
bovin
serum
fb
centrifug
min
g
specif
viral
inocula
determin
uninocul
cell
includ
neg
control
studi
cell
incub
c
harvest
stain
analysi
follow
media
aspir
cell
wash
three
time
phosphat
buffer
salin
pb
cell
overlaid
l
trypl
trypsin
replac
invitrogen
carlsbad
ca
addit
ml
mem
fb
cell
transfer
ml
microcentrifug
tube
centrifug
min
g
cell
monolay
due
cytopath
effect
cpe
overli
media
addit
save
centrifug
cell
pellet
wash
l
pb
centrifug
min
g
resuspend
l
pb
fix
perm
cell
permeabil
kit
invitrogen
use
viral
stain
follow
manufactur
direct
briefli
cell
transfer
ml
tube
incub
l
reagent
min
room
temperatur
cell
wash
ml
pb
fb
centrifug
min
g
resuspend
l
reagent
b
permeabil
medium
one
drop
approxim
l
primari
antibodi
includ
panenteroviru
diagnost
hybrid
inc
dhi
athen
oh
normal
mous
igg
isotyp
control
coxsackieviru
b
blend
polioviru
blend
enteroviru
blend
echoviru
blend
antibodi
millipor
billerica
case
echoviru
echoviru
antibodi
test
echoviru
individu
antibod
i
direct
echoviru
test
coxsackieviru
individu
antibodi
direct
coxsackieviru
test
min
incub
room
temperatur
dark
cell
wash
ml
pb
fb
centrifug
min
g
resuspend
l
reagent
b
one
drop
secondari
antibodi
fluorescein
isothiocyan
fitc
conjug
mous
monoclon
antibodi
dhi
millipor
cell
incub
min
room
temperatur
dark
wash
centrifug
cell
resuspend
l
pb
contain
paraformaldehyd
analyz
flow
cytometri
immedi
antibodi
use
monoclon
antibodi
blend
monoclon
antibodi
flow
cytomet
instrument
setup
perform
daili
use
flowcheck
flowset
fluorospher
beckman
coulter
miami
fl
stain
sampl
analyz
use
fc
flow
cytomet
beckman
coulter
miami
fl
creat
listmod
file
contain
least
event
listmod
file
analyz
use
cxp
beckman
coulter
miami
fl
flowjo
tree
star
ashland
softwar
cell
prepar
tradit
ifa
stain
use
trypsin
wash
cell
prepar
describ
l
cell
suspens
spot
slide
dri
slide
warmer
set
c
fix
cold
aceton
min
one
drop
primari
antibodi
place
well
slide
incub
c
dark
min
slide
wash
pb
distil
water
airdri
one
drop
fitcconjug
secondari
antibodi
place
well
slide
incub
c
dark
min
rins
pb
distil
water
coverslip
place
slide
use
mount
media
dhi
examin
fluoresc
microscop
posit
fluoresc
green
stain
cell
uninocul
cell
stain
enterovirusspecif
antibodi
enterovirusinfect
cell
stain
normal
mous
antibodi
includ
control
initi
feasibl
studi
flow
cytometr
analysi
perform
pmk
cell
show
cpe
follow
infect
echoviru
echoviru
echoviru
echoviru
coxsackieviru
percentag
infect
cell
quantifi
first
gate
forward
side
scatter
signal
help
elimin
cell
debri
noncellular
event
may
present
neg
control
level
determin
use
isotyp
control
antibodi
gave
similar
result
unstain
cell
cell
stain
antibodi
direct
irrelev
enteroviru
serotyp
infect
cell
repres
gate
cellular
event
stain
neg
control
level
use
viru
specif
antibodi
shown
fig
coxsackieviru
cell
demonstr
posit
stain
panenteroviru
coxsackieviru
b
blend
coxsackieviru
antibodi
neg
isotyp
control
echoviru
blend
enteroviru
blend
polioviru
blend
coxsackieviru
antibodi
repres
data
shown
fig
demonstr
echoviru
cell
posit
echoblend
echoviru
antibodi
neg
echoviru
individu
specif
antibodi
threshold
use
fig
base
subject
criteria
natur
break
posit
neg
cell
could
illustr
allow
easi
comparison
infect
cell
neg
control
pmk
cell
infect
echoviru
echoviru
echoviru
demonstr
posit
stain
panenteroviru
echoviru
blend
antibodi
neg
isotyp
control
enteroviru
blend
coxsackieviru
b
blend
polioviru
blend
antibodi
shown
echoviru
cell
addit
posit
echoviru
antibodi
rhinoviru
cell
stain
similarli
uninocul
cell
panenteroviru
echoviru
blend
coxsackieviru
b
blend
isotyp
antibodi
case
ifa
demonstr
qualit
similar
result
compar
flow
cytometri
determin
percentag
pmk
cell
shell
vial
inocul
echoviru
coxsackieviru
analyz
flow
cytometri
h
inocul
cell
examin
cpe
ifa
parallel
flow
cytometr
test
coxsackieviru
flow
cytometri
ifa
detect
panenteroviru
coxsackieviru
blend
coxsackieviru
antibodystain
cell
day
inocul
ifa
becam
posit
day
inocul
fig
tabl
threshold
use
fig
set
allow
one
posit
event
uninfect
cell
control
posit
event
consid
stain
threshold
level
similar
result
obtain
echoviru
pmk
cell
detect
antibodi
stain
panenteroviru
echoviru
blend
found
flow
cytometri
day
cell
inocul
wherea
ifa
detect
positivestain
cell
antibodi
day
inocul
echoviru
coxsackieviru
cell
cpe
becam
evid
time
ifa
posit
differ
antibodi
panenteroviru
coxsackieviru
b
blend
coxsackieviru
antibodi
coxsackieviru
cell
panenteroviru
echoviru
blend
antibodi
echoviru
cell
use
monitor
time
enteroviru
infect
pmk
shell
vial
cell
gave
similar
result
applic
flow
cytometri
mani
vari
wellstudi
detect
enteroviru
infect
cultur
previou
studi
focus
use
flow
cytometri
quantit
polioviru
infect
neuron
cell
daley
et
al
character
enteroviru
bind
host
cell
surfac
freistadt
eberl
mbida
et
al
triantafil
et
al
confirm
cytomegaloviru
infect
tissu
cultur
cell
genet
engin
fluoresc
report
system
kung
et
al
serotyp
human
immunodefici
viru
type
zollapazn
et
al
first
report
clini
tabl
kinet
studi
coxsackieviru
pmk
cell
demonstr
flow
cytometr
analysi
ifa
observ
cpe
data
flow
cytometri
ifa
cell
stain
coxsackieviru
b
blend
antibodi
flow
cytometri
detect
posit
stain
infect
cell
day
prior
ifa
appear
cpe
cal
applic
flow
cytometri
detect
enteroviru
cultur
studi
flow
cytometri
prove
sensit
method
detect
fluoresc
stain
enterovirusinfect
cell
echoviru
coxsackieviru
pmk
cell
flow
cytometri
abl
detect
infect
day
viral
infect
becam
detect
ifa
like
due
abil
flow
cytometri
quickli
analyz
larger
number
cell
routin
examin
ifa
also
abl
quantit
level
infect
even
low
number
virusinfect
cell
capac
quantit
allow
monitor
enteroviru
infect
pmk
cell
period
use
differ
antibodi
gave
similar
result
coxsackieviru
strain
use
studi
highli
effici
infect
pmk
cell
compar
echoviru
strain
predilect
differ
enteroviru
serotyp
even
strain
within
serotyp
differ
cell
line
wellknown
et
al
surpris
differ
rate
infect
two
serotyp
use
studi
observ
fals
posit
occur
flow
cytometr
analysi
infect
cell
neg
stain
isotyp
control
antibodi
antibodi
direct
enteroviru
serotyp
surpris
specif
flow
cytometri
gener
relat
particular
antibodi
employ
therefor
similar
microscopi
base
detect
method
use
antibodi
also
uninocul
cell
demonstr
posit
stain
antibodi
use
studi
addit
human
enteroviru
serotyp
use
method
warrant
type
enterovirus
sequenc
analysi
emerg
accur
surrog
convent
serotyp
method
oberst
et
al
highli
variabl
region
target
genotyp
studi
degener
primer
sequenc
andor
nest
design
necessari
ensur
adequ
sensit
use
antibodybas
method
flow
cytometri
ifa
may
advantag
better
consist
identifi
enteroviru
serotyp
flow
cytometri
also
potenti
faster
less
expens
molecular
method
viral
type
although
flow
cytometr
analysi
shown
highli
sensit
current
method
cumbersom
optim
perform
clinic
laboratori
shell
vial
use
facilit
infect
cell
centrifug
commonli
done
clinic
virolog
laboratori
possibl
effici
tissu
cultur
system
could
employ
use
multipl
well
plate
eg
plate
format
way
need
handl
numer
shell
vial
per
specimen
obviat
other
found
use
centrifug
multipl
well
plate
combin
blind
immunoperoxidas
stain
enteroviru
rapid
sensit
bourlet
et
al
terletskaialadwig
et
al
method
potenti
perform
use
fluoresc
antibodi
stain
follow
flow
cytometr
analysi
instead
pmk
cell
grow
surfac
monolay
trypsin
use
creat
optim
singl
cell
suspens
grogan
collin
anoth
potenti
option
use
lymphocyt
monocyt
cell
line
describ
cultiv
limit
number
enteroviru
serotyp
okada
et
al
skarsvik
et
al
vuorinen
et
al
vuorinen
et
al
cultiv
enteroviru
manner
would
facilit
interrog
flow
cytometri
may
studi
futur
cell
line
routin
use
clinic
laboratori
isol
enteroviru
eg
rd
bgm
also
investig
directli
label
antibodi
commerci
avail
enterovirus
would
use
streamlin
protocol
describ
multicolor
flow
cytometri
could
use
simultan
monitor
infect
differ
cell
type
andor
virus
singl
cultur
thu
modif
method
describ
studi
could
make
use
flow
cytometri
consider
practic
autom
routin
use
clinic
microbiolog
laboratori
flow
cytometri
effect
use
detect
enterovirusinfect
cell
laboratori
set
potenti
advantag
fluoresc
microscopi
includ
better
quantit
low
level
infect
earlier
detect
viral
infect
cell
cultur
system
could
lead
faster
laboratori
identif
pathogen
virus
use
flow
cytometri
direct
clinic
specimen
explor
could
studi
futur
cellular
specimen
respiratori
tract
prospect
applic
method
patient
isol
still
need
confirm
valid
analys
studi
limit
enteroviru
method
test
discuss
appli
wide
array
clinic
import
virus
adenoviru
emerg
coronavirus
influenza
viru
includ
highli
pathogen
strain
affect
public
health
case
knowledg
serotyp
provid
import
strain
inform
epidemiolog
data
addit
studi
still
need
extend
method
present
virus
optim
detect
strategi
